PL · TED (EU)tender

Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawa produktu leczniczego – Vorasidenib - DZP.242.215.2026

UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU

🤖

AI Summary

Win probability: 25%

A Polish university hospital (UKK im. Jana Mikulicza-Radeckiego in Wrocław) is seeking supply of Vorasidenib, a pharmaceutical product classified as an antineoplastic and immunomodulating agent for systemic use. The tender requires suppliers to deliver this medicinal product, likely under framework agreements typical of Polish healthcare procurement. Eligibility requires pharmaceutical distribution authorization and compliance with Polish and EU pharmaceutical regulations.

View & apply on TED (EU)

Applications are submitted on the official government portal. Minted Tenders helps you find and track opportunities — we don't process applications.

Details

Source
TED (EU)
Country
Poland
Type
Tender
Status
Active
Buyer
UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU
Deadline
22 Jun 2026
Sectors
supplies
View & apply on TED (EU)

Applications submitted on the official portal — not via Minted Tenders.